In Washington, researchers used blood from a National Children’s Study biobank to identify more accurate reference intervals for various hormones and amino acids in newborns across a diverse population. The more defined reference intervals could help with earlier diagnosis of diseases like diabetes and pediatric cancer as well as lead to a better understanding of physical and neurological development. As we know, newborns are tiny and its often difficult to draw a significant amount of blood from them for testing, which has proven to be a challenge in the past for researchers to have enough blood to test and reference. The hope is with this research, doctors will have a more accurate reference interval to refer to when testing pediatric patients for developmental issues or diseases.
Latest article
Dutch Queen promotes biobased building materials
In the Netherlands, Dutch Queen consort Máxima visited two Uden worksites promoting biobased building materials made from Netherlands fiber crops.
The March 26 visit...
ReefCircular launches crowdfunding campaign for shell bioconcrete
In Denmark, ReefCircular, a company developing a shell-based bioconcrete to help restore marine habitats, has launched a crowdfunding campaign on Kickstarter.
The company’s bioconcrete...
Aleph Farms raises $29 million for lab-grown steak
In Israel, cultivated meat producer Aleph Farms has raised $29 million to expand production at its Rehovot pilot plant and expand production into Europe...